Both in Pharmaceuticals
Arcus Biosciences vs Arcutis Biotherapeutics
Over the past year RCUS returned +92.6% and ARQT returned +43.7%; their daily moves had a correlation of 0.28.
RCUS +92.6% ARQT +43.7%Growth of $1, one year, split-adjusted
| Metric | RCUS | ARQT |
|---|---|---|
| Price | $25.65 | $26.75 |
| Market cap | $3.27B | $3.36B |
| Today | +2.56% | −2.12% |
| 1 month | −12.2% | +12.5% |
| 6 months | +24.2% | +25.4% |
| Year to date | +7.6% | −7.9% |
| 1 year | +99.8% | +52.2% |
| Revenue growth (YoY) | −74.4% | +59.3% |
| Gross margin | 100.0% | 91.6% |
| Net margin | −222.0% | 11.6% |
| P/E (TTM) | — | 117.9× |
| Price / sales | 27.9× | 7.2× |
| Net cash | $601.0M | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 46.8% |
| Short % of float | 15.5% | 16.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).